- Supported exchanges /
- F /
- 6IV.F
INVENTIVA S.A.(PROM.)-01 (6IV F) stock market data APIs
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
INVENTIVA S.A.(PROM.)-01 Financial Data Overview
| 2.62 | |
| 2.47 | |
| - | |
| 2.62 | |
| 2.47 | |
| 1.448-4.205 | |
| 212 M | |
| 52 362 K | |
| 19 275 K | |
| 1.013 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
INVENTIVA S.A.(PROM.)-01 Fundamental Data is available in our Financial Data APIs
- Net Revenue 19 275 K
- EBITDA -98 356 000
- Earnings Per Share -2.06
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get INVENTIVA S.A.(PROM.)-01 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get INVENTIVA S.A.(PROM.)-01 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
